KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Accounts Payables (2016 - 2026)

Encompass Health (EHC) has disclosed Accounts Payables for 18 consecutive years, with $204.0 million as the latest value for Q1 2026.

  • For Q1 2026, Accounts Payables rose 28.22% year-over-year to $204.0 million; the TTM value through Mar 2026 reached $204.0 million, up 28.22%, while the annual FY2025 figure was $178.2 million, 4.21% up from the prior year.
  • Accounts Payables hit $204.0 million in Q1 2026 for Encompass Health, up from $178.2 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $204.0 million in Q1 2026 and bottomed at $132.9 million in Q4 2022.
  • Average Accounts Payables over 5 years is $159.5 million, with a median of $164.2 million recorded in 2024.
  • Year-over-year, Accounts Payables fell 18.73% in 2025 and then rose 28.22% in 2026.
  • Encompass Health's Accounts Payables stood at $132.9 million in 2022, then grew by 27.92% to $170.0 million in 2023, then grew by 0.59% to $171.0 million in 2024, then rose by 4.21% to $178.2 million in 2025, then grew by 14.48% to $204.0 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $204.0 million, $178.2 million, and $138.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.